Effects of Osteopathic Management on Disability and Quality of Life After Lumbar Arthrodesis
NCT ID: NCT06802120
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-01-02
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For this purpose, We will analyze the effects of these two approaches, targeted and non-targeted osteopathy (TO vs. NTO), on patients' disability and quality of life after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Osteopathy Medicine on Post-surgical Management of Lumbosacral Arthrodesis
NCT06669858
Comparative Study of the Results of Anterior and Posterior Arthrodesis in Degenerative Lumbar Pathology
NCT04115202
Pre-surgery Physiotherapy for Patients With Specific Low Back Pain
NCT02454400
Isthmic Spondylolisthesis Treated With Combined Approach: Clinical and Radiological Outcomes
NCT03585439
Lumbar Stabilization Exercises in Adult Patients With Lumbar Arthrodesis Surgery
NCT03538093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Targeted osteopathic treatment
treatment with real osteopathy
osteopathy real
treatment with real osteopathy 2 times a week for 8 weeks
Non-targeted osteopathic treatment
treatment with sham osteopathy
sham osteopathy
treatment with sham osteopathy 2 times a week for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
osteopathy real
treatment with real osteopathy 2 times a week for 8 weeks
sham osteopathy
treatment with sham osteopathy 2 times a week for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being under a stable pharmacological treatment over the last month
* who are suffering from postoperative mechanical pain (VAS ≥ 4)
Exclusion Criteria
* are suffering from fibromyalgia,
* algodystrophy,
* other somatic or neuropsychiatric diseases (other than depression and anxiety),
* have received osteopathic treatment over the last three month prior to inclusion,
* are included in another interventional research protocol during the study period
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut De La Colonne Vertebrale Et Des Neurosciences
OTHER
Ecole Supérieur d'Ostéopathie
OTHER
Clinique Bizet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Bizet
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Georges ABI LAHOUD, Professeur
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A01768-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.